Zaldivar R, Davidorf J M, Oscherow S, Ricur G, Piezzi V
Instituto Zaldivar, Mendoza, Argentina.
J Refract Surg. 1999 May-Jun;15(3):299-308. doi: 10.3928/1081-597X-19990501-04.
To examine the efficacy, predictability, stability, and safety of combined posterior chamber phakic intraocular lens (IOL) implantation and laser in situ keratomileusis (LASIK) in eyes with extreme myopia.
We analyzed the results of 67 eyes that received a posterior chamber hydrogel-collagen plate phakic IOL (STAAR Collamer Implantable Contact Lens) and also underwent secondary LASIK for the correction of extreme myopia. Mean follow-up was 3 months after the LASIK portion of the procedure (range, 1 day to 6 mo after LASIK).
Mean preoperative spherical equivalent refraction was -23.00 +/- 3.60 D (range, -18.75 to -35.00 D), and mean refractive cylinder was 1.50 +/- 1.20 D (range, 0 to 5.00 D). Mean spherical equivalent refraction after IOL implantation and before LASIK was -6.00 +/- 2.80 D (range, -2.00 to -14.38 D) and mean refractive cylinder 1.50 +/- 1.10 D (range, 0 to 5.00 D). Mean postoperative spherical equivalent refraction at last examination after the LASIK portion of the two-part phakic IOL-LASIK procedure was -0.20 +/- 0.90 D (range, +1.75 to -5.13 D), and mean refractive cylinder was 0.50 +/- 0.50 (range, 0 to 2.25 D). Eighty-five percent (57 eyes) were within +/- 1.00 D and 67% (45 eyes) were within +/- 0.50 D of emmetropia at last examination. The refractions remained stable with a statistically insignificant change (P > .05 at each interval) during follow-up. Postoperative uncorrected visual acuity at last examination was 20/20 or better in 3% (2 eyes) and 20/40 or better in 69% (46 eyes). A gain of 2 or more lines of spectacle-corrected visual acuity was seen in 51 eyes (76%) and no eyes lost 2 or more lines of spectacle-corrected visual acuity at last examination.
Combined posterior chamber phakic IOL implantation with the STAAR Collamer plate lens and LASIK (bioptics) is an effective and reasonably predictable method for correcting myopia from -18 to -35 D. Gains in spectacle-corrected visual acuity were common, and results demonstrated good short-term safety and refractive stability.
探讨后房型有晶状体眼人工晶状体(IOL)植入联合准分子原位角膜磨镶术(LASIK)治疗超高度近视的有效性、可预测性、稳定性及安全性。
分析67例接受后房型水凝胶-胶原板有晶状体眼IOL(STAAR Collamer人工晶状体)植入并二期行LASIK矫正超高度近视患者的结果。LASIK手术部分术后平均随访3个月(范围:LASIK术后1天至6个月)。
术前平均等效球镜度为-23.00±3.60D(范围:-18.75至-35.00D),平均散光度数为1.50±1.20D(范围:0至5.00D)。IOL植入后及LASIK术前平均等效球镜度为-6.00±2.80D(范围:-2.00至-14.38D),平均散光度数为1.50±1.